BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-21 Cr | ₹-15 Cr | ₹-7.49 Cr | ₹-6.54 Cr | ₹-5.35 Cr |
What is the latest Cash Flow from Investing Activities ratio of BAFNA PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-21 Cr |
| Mar2024 | ₹-15 Cr |
| Mar2023 | ₹-7.49 Cr |
| Mar2022 | ₹-6.54 Cr |
| Mar2021 | ₹-5.35 Cr |
How is Cash Flow from Investing Activities of BAFNA PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-21 Cr | Negative | |
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹-7.49 Cr | Negative | |
| Mar2022 | ₹-6.54 Cr | Negative | |
| Mar2021 | ₹-5.35 Cr | - | |
Compare Cash Flow from Investing Activities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹348.2 Cr | -2.6% | 0.3% | 91% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,681.0 Cr | 3.6% | -0.7% | -4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,324.0 Cr | 4.7% | 5% | 9.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,466.0 Cr | 6.3% | 8.9% | 15.8% | Stock Analytics | |
| CIPLA | ₹118,524.0 Cr | -2.2% | -2% | 1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,711.0 Cr | -0.9% | -1.9% | -7.2% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -2.6% |
0.3% |
91% |
| SENSEX | -0.3% |
-0.9% |
6.3% |
You may also like the below Video Courses